Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
100%(1 trials)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

unknown1
Active, not recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

unknown133%
active_not_recruiting133%
completed133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruiting

Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1)

NCT03676010
completednot_applicable

Consumer Responses to Alcohol Warnings

NCT06159647
unknown

The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study

NCT06220630

Clinical Trials (3)

Showing 3 of 3 trials
NCT03676010

Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1)

Active Not Recruiting
NCT06159647Not Applicable

Consumer Responses to Alcohol Warnings

Completed
NCT06220630

The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study

Unknown

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3